Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Findings could lead to new targeted therapies for speech and learning disabilities

A team of University of Oregon researchers have isolated an independent processing channel of synapses inside the brain's auditory cortex that deals specifically with shutting off sound processing at appropriate times.

11 Feb 2010

Neurology researchers explore link between MS and chronic cerebrospinal venous insufficiency

More than 55 percent of multiple sclerosis patients participating in the initial phase of the first randomized clinical study to determine if persons with MS exhibit narrowing of the extracranial veins, causing restriction of normal outflow of blood from the brain, were found to have the abnormality.

11 Feb 2010

fMRI study shows neural network may be brain's back burner for social decision making

When we put an idea on the back burner, it goes into a processing area of the brain called the default-mode network. This network enables us to hold the low-priority idea in abeyance until a time when we aren't busy with something else.

11 Feb 2010

Existing sleep deprivation theory challenged

What goes on in your brain when you're sleep deprived and how does it affect your ability to process information and make decisions?

11 Feb 2010

Migraine sufferers face increase risk of heart attack, says study

People with migraine may be at an increased risk of heart attack and other risk factors for heart disease, according to a study published in the February 10, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

11 Feb 2010

Mental health 'bible' starts revamp with new terminology, diagnoses

The Wall Street Journal: "Mental-health experts wrestling with how to fit temper tantrums, hoarding and even Internet addiction into the current understanding of mental illness are proposing changes to the field's primary reference for diagnoses for the first time in 16 years. The draft revisions of the Diagnostic and Statistical Manual of Mental Disorders—the bible for mental health clinicians and researchers—unveiled Wednesday could have effects that ripple through mental health care."

11 Feb 2010

Neuroimaging study shows brain activity patterns that correlate to decision making process

Faces play a very important role in our social life. We make complex social decisions based on facial appearance. Extensive research has been made to identify a set of facial features which make a face attractive.

10 Feb 2010

Raptor Pharmaceutical to present DR Cysteamine trial data at Lysosomal Disease Network Symposium

Raptor Pharmaceutical Corp., today announced the presentation of cystinosis data at the Annual Lysosomal Disease Network WORLD Symposium 2010, being held February 10-12 in Miami, Florida. Biomarker data from a Phase IIb pilot study of Raptor's proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") will be the subject of a poster titled, "Correlation of Plasma Cysteamine and WBC Cystine Levels at Steady State in Patients Treated with Cysteamine Bitartrate." The results will also be published in an upcoming issue of the journal Molecular Genetics and Metabolism.

10 Feb 2010

Seaside Therapeutics granted U.S patent covering methods of treating autism

Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.

10 Feb 2010

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel glycine site functional partial agonist (GFPA) NMDA receptor modulators, today reported positive top-line results from its Phase I clinical trial of lead compound GLYX-13.

10 Feb 2010

Findings suggest AP patients lack the ability to process faces as a whole

In a new study published in the March 2010 issue of Elsevier's Cortex, researchers have found that the condition is linked to an inability to process faces as a whole, or holistically.

10 Feb 2010

QR Pharma commences clinical trial of Posiphen in early stage AD patients

QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer’s disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.

10 Feb 2010

Renowned experts explore latest key development in nuclear medicine and molecular imaging at 2010 SNM summit

Educators, researchers, physicians, technologists and medical experts from across the country converged on Albuquerque, N.M., last week to explore topics in nuclear medicine, molecular imaging, nanomedicine and clinical trials during SNM's 2010 Conjoint Mid-Winter Meetings.

10 Feb 2010

Brain researchers explore link between emotion and memory

In a novel study that used historical tape of a thrilling overtime basketball game between Duke and the University of North Carolina at Chapel Hill, brain researchers at Duke have found that fans remember the good things their team did much better than the bad.

10 Feb 2010

AANS: Accidental falls are leading cause of non-fatal injury among Americans of all ages

Accidental falls are the leading cause of non-fatal injury among Americans of all ages according to the American Association of Neurological Surgeons (AANS). And among Americans age 65 and older, falls are the leading cause of fatal injuries. Among older adults, traumatic brain injury (TBI) causes nearly 50 percent of fall-related fatalities.

10 Feb 2010

Toronto Rehab scientists develop SoleSensor to help older people stay on their feet

In an aging society, falling is a growing problem. Just one bad fall can mark the start of a downward spiral in an older person's health and quality of life. The cost of treating falls also puts a heavy burden on the health care system. Toronto Rehab scientists have developed a simple footwear insole called SoleSensor(TM), which has proven to improve balance and prevent falls.

10 Feb 2010

SMT Research and Development completes first two clinical cases using Shimon Embolic Filter

SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.

10 Feb 2010

Study may pave way for more refined treatments for brain tumors

Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.

10 Feb 2010

Study of complement reaction can help eliminate reperfusion injuries

Researchers have teased out the molecular process that can shut down a marauding, often deadly immune response that kills thousands each year who suffer battlefield casualties, heart attacks, strokes, automobile accidents and oxygen deprivation, according to an article published in the January edition of Molecular Immunology.

10 Feb 2010

Concentric Medical's Trevo System receives regulatory approval in Europe and Canada

Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that its Trevo System for acute ischemic stroke has received regulatory approval in both Europe (CE Mark) and Canada.

10 Feb 2010

Brain News and Research

Further Reading

Findings could lead to new targeted therapies for speech and learning disabilities

Neurology researchers explore link between MS and chronic cerebrospinal venous insufficiency

fMRI study shows neural network may be brain's back burner for social decision making

Existing sleep deprivation theory challenged

Migraine sufferers face increase risk of heart attack, says study

Mental health 'bible' starts revamp with new terminology, diagnoses

Neuroimaging study shows brain activity patterns that correlate to decision making process

Raptor Pharmaceutical to present DR Cysteamine trial data at Lysosomal Disease Network Symposium

Seaside Therapeutics granted U.S patent covering methods of treating autism

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

Findings suggest AP patients lack the ability to process faces as a whole

QR Pharma commences clinical trial of Posiphen in early stage AD patients

Renowned experts explore latest key development in nuclear medicine and molecular imaging at 2010 SNM summit

Brain researchers explore link between emotion and memory

AANS: Accidental falls are leading cause of non-fatal injury among Americans of all ages

Toronto Rehab scientists develop SoleSensor to help older people stay on their feet

SMT Research and Development completes first two clinical cases using Shimon Embolic Filter

Study may pave way for more refined treatments for brain tumors

Study of complement reaction can help eliminate reperfusion injuries

Concentric Medical's Trevo System receives regulatory approval in Europe and Canada

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News